Spyre Therapeutics
SYRE
#5838
Rank
C$1.09 B
Marketcap
$18.18
Share price
-8.58%
Change (1 day)
-62.06%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2024 (TTM): -$96.12

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -$102.61. In 2023 the company made an earnings per share (EPS) of -$69.83 a decrease over its 2022 EPS that were of -$35.18.

EPS history for Spyre Therapeutics from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$96.1237.66%
2023-$69.8398.46%
2022-$35.18-1%
2021-$35.54-34.21%
2020-$54.02-37.96%
2019-$87.0715.02%
2018-$75.7018.33%
2017-$63.97-18.92%
2016-$78.90120.2%
2015-$35.83-33.55%
2014-$53.92